Polar Asset Management Partners’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-47,400
Closed -$9.29M 822
2023
Q3
$9.29M Buy
+47,400
New +$9.73M 0.21% 133
2023
Q2
Sell
-38,700
Closed -$7.81M 985
2023
Q1
$7.81M Buy
38,700
+16,900
+78% +$3.83M 0.12% 233
2022
Q4
$4.75M Sell
21,800
-73,500
-77% -$16.1M 0.06% 435
2022
Q3
$18.8M Buy
+95,300
New +$20.6M 0.22% 98
2021
Q1
Sell
-136,000
Closed -$34M 972
2020
Q4
$34M Sell
136,000
-30,700
-18% -$7.31M 0.37% 35
2020
Q3
$37.7M Buy
166,700
+96,700
+138% +$20.1M 0.52% 28
2020
Q2
$12.2M Buy
70,000
+6,200
+10% +$989K 0.2% 133
2020
Q1
$8.05M Buy
+63,800
New +$9.57M 0.16% 145

Other funds holding CRL

Polar Asset Management Partners's CRL Position: Q4 2023 in Review

Polar Asset Management Partners sold out of Charles River Laboratories (CRL) in Q4 2023, closing a stake of 47,400 shares — an estimated $9.29M sold.

Polar Asset Management Partners first reported a position in CRL in Q1 2020 and held it in 8 quarters. The position peaked at $37.7M in Q3 2020. 634 funds tracked by Wall St. Rank hold CRL as of Q4 2023.

  • Polar Asset Management Partners reported no remaining Charles River Laboratories position as of Q4 2023 after selling out during the quarter.
  • Polar Asset Management Partners sold 47,400 Charles River Laboratories shares in Q4 2023, an estimated $9.29M.
  • Polar Asset Management Partners first reported a position in Charles River Laboratories in Q1 2020 and held it in 8 quarters.
  • Polar Asset Management Partners's Charles River Laboratories position peaked at $37.7M in Q3 2020.
  • 634 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2023.

Based on Polar Asset Management Partners's 13F filing for Q4 2023, filed 14 Feb 2024.